本页面由Tiger Trade Technology Pte. Ltd.提供服务

Dare Bioscience

0.7501
-0.0233-3.01%
盘后:0.75010.00000.00%19:52 EDT
成交量:8.20万
成交额:6.17万
市值:1,475.38万
市盈率:-0.96
高:0.7901
开:0.7700
低:0.7381
收:0.7734
52周最高:3.78
52周最低:0.6900
股本:1,966.91万
流通股本:1,732.62万
量比:0.68
换手率:0.47%
股息:- -
股息率:- -
每股收益(TTM):-0.7779
每股收益(LYR):-1.1986
净资产收益率:-2543.13%
总资产收益率:-39.29%
市净率:-26.31
市盈率(LYR):-0.63

数据加载中...

2019/06/27

重要事件披露

Current report, item 3.01
2019/06/14

重要事件披露

Current report, item 5.07
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/14

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/03

重要事件披露

Current report, items 8.01 and 9.01
2019/05/20

重要事件披露

Current report, items 8.01 and 9.01
2019/05/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/05/14

重要事件披露

Current report, items 2.02 and 9.01
2019/04/16

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/04/15

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/04/15

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/04/15

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/09/20

SEC问询函

[Cover]Correspondence